课题基金 / 基金详情

项目摘要

项目成果

MACIEJ S LESNIAK的其他基金

相似基金

相关文献

中文摘要
翻译
管理核心:摘要 西北脑肿瘤孢子管理核心将提供结构和组织, 研究计划,并将在Lesniak博士(PI)和James博士(Co-PI)的指导下运作, 在内部和外部咨询委员会的指导下。的 核心领导者是有成就的脑肿瘤研究人员,是肿瘤生物学、实验 治疗学和临床前以及临床研究。因此,他们完全有资格监督这一点 孢子,并看到它的生产力以及对脑肿瘤患者的治疗结果的影响。基于 根据委员会和咨询委员会的建议,核心董事将对任何问题做出最终决定。 这涉及SPORE的及时进展。此外,作为核心董事,他们将拥有全面的科学和 对此次收购承担经济责任。他们将支付资金,并将收到定期会计, 每个项目的财务状况。核心研究的工作人员支持将由Lurie癌症中心(LCC)提供 管理员Robin Leikin博士,赠款和合同管理员丹尼尔拉德马赫先生, 项目/倡导管理员安吉拉·帕克女士和病人倡导者保罗·卢卡奇博士。通过努力 这些个人和活动的行政核心,机制将到位,程序适用 实现高质量、团队导向和富有成效的调查。
英文摘要
ADMINISTRATIVE CORE: SUMMARY The Northwestern Brain Tumor SPORE Administrative Core will provide structure and organization to this program of research, and will function under the direction of Drs. Lesniak (PI) and James (Co-PI), with input from the SPORE Executive Committee, and with guidance from the Internal and External Advisory Boards. The core leaders are accomplished brain tumor researchers, and are experts in tumor biology, experimental therapeutics, and preclinical as well as clinical studies. As such they are well qualified to supervise this SPORE, and see to its productivity as well as impact on treatment outcomes for brain tumor patients. Based on committee and advisory board recommendations, the Core Directors will make final decisions on any issues that involve the timely progression of the SPORE. Further, as core directors they will have overall scientific and financial responsibility for this SPORE. They will disburse funds and will receive regular accounting of the financial status of each project. Staff support for the Core will be provided by Lurie Cancer Center (LCC) Administrator Dr. Robin Leikin, Grants and Contracts Administrator Mr. Daniel Rademacher, Program/Advocacy Administrator Ms. Angela Park, and patient advocate Dr. Paul Lukac. Through the efforts of these individuals and activities of the Administrative Core, mechanisms will be in place and procedures applied for enabling high quality, team-oriented, and productive investigations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
SPORE for Translational Approaches to Brain Cancer
海外基金